お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
916449

呼吸器診断の世界市場:産業動向、シェア、規模、成長、機会、および予測(2019年~2024年)

Respiratory Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 106 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.53円
呼吸器診断の世界市場:産業動向、シェア、規模、成長、機会、および予測(2019年~2024年)
出版日: 2019年10月20日
発行: IMARC Services Private Limited
ページ情報: 英文 106 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の呼吸器診断市場は、2018年に44億米ドルに達しました。

当レポートは世界の呼吸器診断市場について調査しており、産業の動向、市場予測、製品およびサービス・検査・疾患・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 序文

第2章 範囲および調査方法

  • 調査の目的
  • 利害関係者
  • 情報源
    • 一次情報源
    • 二次情報源
  • 市場予測
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測方法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主な産業動向

第5章 世界市場

  • 市場概況
  • 市場実績
  • 製品・サービスタイプ別
  • 検査タイプ別
  • 疾患別
  • エンドユーザー別
  • 地域別

第6章 市場分析:製品・サービスタイプ別

  • 機器・サービス
  • アッセイ・試薬
  • サービス・ソフトウェア

第7章 市場分析:検査タイプ別

  • 機械的試験
  • 閉塞性睡眠時無呼吸(OSA)診断検査
  • 画像検査
  • 従来の診断テスト
  • 分子診断検査
  • その他

第8章 市場分析:疾患別

  • 結核
  • 喘息
  • 慢性閉塞性肺疾患(COPD)
  • 肺癌
  • その他

第9章 市場分析:エンドユーザー別

  • 病院
  • 診療所
  • 参照・臨床検査室
  • その他

第10章 市場分析:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 市場機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 業界内の競争
  • 新規参入の脅威
  • 代替品の脅威

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 企業プロファイル
    • Philips Healthcare
    • Abbott Laboratories
    • Biomerieux
    • Becton Dickinson
    • Thermo Fisher Scientific Inc.
    • Alere Inc.
    • Seegene Inc.
    • 3M
    • Bio-Rad Laboratories Inc.
    • SDI Diagnostics
    • COSMED
図表

List of Figures

  • Figure 1: Global: Respiratory Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Respiratory Diagnostics Market: Sales Value (in Billion US$), 2013-2018
  • Figure 3: Global: Respiratory Diagnostics Market: Breakup by Product and Service Type (in %), 2018
  • Figure 4: Global: Respiratory Diagnostics Market: Breakup by Test Type (in %), 2018
  • Figure 5: Global: Respiratory Diagnostics Market: Breakup by Disease (in %), 2018
  • Figure 6: Global: Respiratory Diagnostics Market: Breakup by End User (in %), 2018
  • Figure 7: Global: Respiratory Diagnostics Market: Breakup by Region (in %), 2018
  • Figure 8: Global: Respiratory Diagnostics Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 9: Global: Respiratory Diagnostics Industry: SWOT Analysis
  • Figure 10: Global: Respiratory Diagnostics Industry: Value Chain Analysis
  • Figure 11: Global: Respiratory Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Respiratory Diagnostics (Instruments and Services) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 13: Global: Respiratory Diagnostics (Instruments and Services) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 14: Global: Respiratory Diagnostics (Assays and Reagents) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 15: Global: Respiratory Diagnostics (Assays and Reagents) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 16: Global: Respiratory Diagnostics (Services and Software) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 17: Global: Respiratory Diagnostics (Services and Software) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 18: Global: Respiratory Diagnostics (Mechanical Tests) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 19: Global: Respiratory Diagnostics (Mechanical Tests) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 20: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 21: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 22: Global: Respiratory Diagnostics (Imaging Tests) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 23: Global: Respiratory Diagnostics (Imaging Tests) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 24: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 25: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 26: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 27: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 28: Global: Respiratory Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 29: Global: Respiratory Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 30: Global: Respiratory Diagnostics (Tuberculosis) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 31: Global: Respiratory Diagnostics (Tuberculosis) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 32: Global: Respiratory Diagnostics (Asthma) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 33: Global: Respiratory Diagnostics (Asthma) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 34: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 35: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 36: Global: Respiratory Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 37: Global: Respiratory Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 38: Global: Respiratory Diagnostics (Other Disease Types) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 39: Global: Respiratory Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 40: Global: Respiratory Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 41: Global: Respiratory Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 42: Global: Respiratory Diagnostics (Clinics) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 43: Global: Respiratory Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 44: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 45: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 46: Global: Respiratory Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 47: Global: Respiratory Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 48: North America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 49: North America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 50: Europe: Respiratory Diagnostics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 51: Europe: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 52: Asia Pacific: Respiratory Diagnostics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 53: Asia Pacific: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 54: Middle East and Africa: Respiratory Diagnostics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 55: Middle East and Africa: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 56: Latin America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 57: Latin America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

  • Table 1: Global: Respiratory Diagnostics Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Global: Respiratory Diagnostics Market Forecast: Breakup by Product and Service Type (in Million US$), 2019-2024
  • Table 3: Global: Respiratory Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2019-2024
  • Table 4: Global: Respiratory Diagnostics Market Forecast: Breakup by Disease (in Million US$), 2019-2024
  • Table 5: Global: Respiratory Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2019-2024
  • Table 6: Global: Respiratory Diagnostics Market Forecast: Breakup by Region (in Million US$), 2019-2024
  • Table 7: Global: Respiratory Diagnostics Market Structure
  • Table 8: Global: Respiratory Diagnostics Market: Key Players
目次
Product Code: SR1019F27_Report

The global respiratory diagnostics market reached a value of US$ 4.4 Billion in 2018. Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe. Looking forward, IMARC Group expects the market to reach a value of US$ 6.5 Billion by 2024, registering a CAGR of 6.6% during 2019-2024.

Report Coverage:

Historical, Current and Future Market Trends

Market Breakup by Product and Service Type:

  • Instruments and Services
  • Assays and Reagents
  • Services and Software

Market Breakup by Test Type:

  • Mechanical Tests
  • Obstructive Sleep Apnoea (OSA) Diagnostic Tests
  • Imaging Tests
  • Traditional Diagnostic Tests
  • Molecular Diagnostic Tests
  • Others

Market Breakup by Disease:

  • Tuberculosis
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Cancer
  • Others

Market Breakup by End-User:

  • Hospitals
  • Clinics
  • Reference and Clinical Laboratories
  • Others

Market Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape

The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific, Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics, COSMED, etc.

Key Questions Answered in This Report:

  • How has the global respiratory diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global respiratory diagnostics industry?
  • What is the breakup of the market based on the products and service type?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global respiratory diagnostics industry?
  • What are the key driving factors and challenges in the global respiratory diagnostics industry?
  • What is the structure of the global respiratory diagnostics industry and who are the key players?
  • What is the degree of competition in the global respiratory diagnostics industry?

Table of Contents

1. Preface

2. Scope and Methodology

  • 2.1. Objectives of the Study
  • 2.2. Stakeholders
  • 2.3. Data Sources
    • 2.3.1. Primary Sources
    • 2.3.2. Secondary Sources
  • 2.4. Market Estimation
    • 2.4.1. Bottom-Up Approach
    • 2.4.2. Top-Down Approach
  • 2.5. Forecasting Methodology

3. Executive Summary

4. Introduction

  • 4.1. Overview
  • 4.2. Key Industry Trends

5. Global Respiratory Diagnostics Market

  • 5.1. Market Overview
  • 5.2. Market Performance
  • 5.3. Market Breakup by Product and Service Type
  • 5.4. Market Breakup by Test Type
  • 5.5. Market Breakup by Disease
  • 5.6. Market Breakup by End-User
  • 5.7. Market Breakup by Region
  • 5.8. Market Forecast

6. Market Breakup by Product and Service Type

  • 6.1. Instruments and Services
    • 6.1.1. Market Trends
    • 6.1.2. Market Forecast
  • 6.2. Assays and Reagents
    • 6.2.1. Market Trends
    • 6.2.2. Market Forecast
  • 6.3. Services and Software
    • 6.3.1. Market Trends
    • 6.3.2. Market Forecast

7. Market Breakup by Test Type

  • 7.1. Mechanical Tests
    • 7.1.1. Market Trends
    • 7.1.2. Market Forecast
  • 7.2. Obstructive Sleep Apnoea (OSA) Diagnostic Tests
    • 7.2.1. Market Trends
    • 7.2.2. Market Forecast
  • 7.3. Imaging Tests
    • 7.3.1. Market Trends
    • 7.3.2. Market Forecast
  • 7.4. Traditional Diagnostic Tests
    • 7.4.1. Market Trends
    • 7.4.2. Market Forecast
  • 7.5. Molecular Diagnostic Tests
    • 7.5.1. Market Trends
    • 7.5.2. Market Forecast
  • 7.6. Others
    • 7.6.1. Market Trends
    • 7.6.2. Market Forecast

8. Market Breakup by Disease

  • 8.1. Tuberculosis
    • 8.1.1. Market Trends
    • 8.1.2. Market Forecast
  • 8.2. Asthma
    • 8.2.1. Market Trends
    • 8.2.2. Market Forecast
  • 8.3. Chronic Obstructive Pulmonary Disease (COPD)
    • 8.3.1. Market Trends
    • 8.3.2. Market Forecast
  • 8.4. Lung Cancer
    • 8.4.1. Market Trends
    • 8.4.2. Market Forecast
  • 8.5. Others
    • 8.5.1. Market Trends
    • 8.5.2. Market Forecast

9. Market Breakup by End User

  • 9.1. Hospitals
    • 9.1.1. Market Trends
    • 9.1.2. Market Forecast
  • 9.2. Clinics
    • 9.2.1. Market Trends
    • 9.2.2. Market Forecast
  • 9.3. Reference and Clinical Laboratories
    • 9.3.1. Market Trends
    • 9.3.2. Market Forecast
  • 9.4. Others
    • 9.4.1. Market Trends
    • 9.4.2. Market Forecast

10. Market Breakup by Region

  • 10.1. North America
    • 10.1.1. Market Trends
    • 10.1.2. Market Forecast
  • 10.2. Europe
    • 10.2.1. Market Trends
    • 10.2.2. Market Forecast
  • 10.3. Asia Pacific
    • 10.3.1. Market Trends
    • 10.3.2. Market Forecast
  • 10.4. Middle East and Africa
    • 10.4.1. Market Trends
    • 10.4.2. Market Forecast
  • 10.5. Latin America
    • 10.5.1. Market Trends
    • 10.5.2. Market Forecast

11. SWOT Analysis

  • 11.1. Overview
  • 11.2. Strengths
  • 11.3. Weaknesses
  • 11.4. Opportunities
  • 11.5. Threats

12. Value Chain Analysis

13. Porters Five Forces Analysis

  • 13.1. Overview
  • 13.2. Bargaining Power of Buyers
  • 13.3. Bargaining Power of Suppliers
  • 13.4. Degree of Competition
  • 13.5. Threat of New Entrants
  • 13.6. Threat of Substitutes

14. Competitive Landscape

  • 14.1. Market Structure
  • 14.2. Key Players
  • 14.3. Profiles of Key Players
    • 14.3.1. Philips Healthcare
    • 14.3.2. Abbott Laboratories
    • 14.3.3. Biomerieux
    • 14.3.4. Becton Dickinson
    • 14.3.5. Thermo Fisher Scientific Inc.
    • 14.3.6. Alere Inc.
    • 14.3.7. Seegene Inc.
    • 14.3.8. 3M
    • 14.3.9. Bio-Rad Laboratories Inc.
    • 14.3.10. SDI Diagnostics
    • 14.3.11. COSMED
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.